This shows you the differences between two versions of the page.
Both sides previous revision Previous revision | Next revision Both sides next revision | ||
ohdsi-questions [2018/03/21 07:25] rohit ↷ Page name changed from rohit to ohdsi-questions |
ohdsi-questions [2018/04/13 23:45] rohit |
||
---|---|---|---|
Line 55: | Line 55: | ||
-Comparator Cohort - Patients treated with triptans for one year (short-term) and patients treated with triptans for more than one year (long-term). | -Comparator Cohort - Patients treated with triptans for one year (short-term) and patients treated with triptans for more than one year (long-term). | ||
-Outcome - Sudden cardiac death, acute myocardial infarction, and stroke after exposure. | -Outcome - Sudden cardiac death, acute myocardial infarction, and stroke after exposure. | ||
- | -Risk Window - 1 day after treatment exposure starts to 0 days after treatment exposure ends. | + | -Risk Window - 1 day after treatment exposure starts to 0 days after treatment exposure ends. |
+ | |||
+ | ===Question - 9=== | ||
+ | To compare the risk of osteoporosis or fracture increase in postmenopausal hypothyroid patients using high strength levothyroxine versus patients using low strength levothyroxine. | ||
+ | -Treatment Cohort - On treatment postmenopausal (age >=50 years) patients with hypothyroidism exposed to high strength of levothyroxine (>=0.044 mg/day). | ||
+ | -Comparator Cohort - On treatment postmenopausal (age >=50 years) patients with hypothyroidism exposed to low strength of levothyroxine (< 0.044 mg/day). | ||
+ | -Outcome - Osteoporosis or Fracture. | ||
+ | -Risk Window: From the first day of treatment with high or low strength levothyroxine until the end of cohort study, end of follow-up or death. | ||
+ | |||
+ | |||
More discussion on these question can be seen here at [[http:// | More discussion on these question can be seen here at [[http:// |